These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

111 related articles for article (PubMed ID: 9384211)

  • 1. Re: "Confounding by indication and channeling over time: the risks of beta2-agonists".
    Pearce N; Beasley R; Crane J; Burgess C
    Am J Epidemiol; 1997 Nov; 146(10):885-7. PubMed ID: 9384211
    [No Abstract]   [Full Text] [Related]  

  • 2. Confounding by indication and channeling over time: the risks of beta 2-agonists.
    Blais L; Ernst P; Suissa S
    Am J Epidemiol; 1996 Dec; 144(12):1161-9. PubMed ID: 8956629
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Asthma and the beta agonist debate.
    Crane J; Pearce N; Burgess C; Beasley R
    Thorax; 1995 Sep; 50 Suppl 1(Suppl 1):S5-10. PubMed ID: 7570465
    [No Abstract]   [Full Text] [Related]  

  • 4. Epidemiologic studies of beta agonists and asthma deaths.
    Pearce N; Hensley MJ
    Epidemiol Rev; 1998; 20(2):173-86. PubMed ID: 9919437
    [No Abstract]   [Full Text] [Related]  

  • 5. Fenoterol: the evidence leading to restriction of it use.
    Elwood JM
    N Z Med J; 1990 Aug; 103(896):395-7. PubMed ID: 2200989
    [No Abstract]   [Full Text] [Related]  

  • 6. Risk of severe life threatening asthma.
    Barnes NC; Kuitert LM
    Thorax; 1996 Nov; 51(11):1073. PubMed ID: 8958886
    [No Abstract]   [Full Text] [Related]  

  • 7. Rise and fall of asthma-related mortality in Italy and sales of beta2-agonists, 1980-1994.
    Romano F; Recchia G; Staniscia T; Bonitatibus A; Villa M; Nicolosi A; De Carli G; Mannino S
    Eur J Epidemiol; 2000; 16(9):783-7. PubMed ID: 11297218
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The use of beta agonists and the risk of death and near death from asthma.
    Pearce N
    J Clin Epidemiol; 2009 Jun; 62(6):582-7. PubMed ID: 19422997
    [No Abstract]   [Full Text] [Related]  

  • 9. Confounding by severity does not explain the association between fenoterol and asthma death.
    Beasley R; Burgess C; Pearce N; Woodman K; Crane J
    Clin Exp Allergy; 1994 Jul; 24(7):660-8. PubMed ID: 7953948
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Risk of severe life threatening asthma and beta agonist type: an example of confounding by severity.
    Garrett JE; Lanes SF; Kolbe J; Rea HH
    Thorax; 1996 Nov; 51(11):1093-9. PubMed ID: 8958891
    [TBL] [Abstract][Full Text] [Related]  

  • 11. International trends in sales of inhaled fenoterol, all inhaled beta-agonists, and asthma mortality, 1970-1992.
    Lanes SF; Birmann B; Raiford D; Walker AM
    J Clin Epidemiol; 1997 Mar; 50(3):321-8. PubMed ID: 9120532
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Matching or selection bias in the fenoterol studies?
    Lanes SF
    N Z Med J; 1992 Oct; 105(943):413-4. PubMed ID: 1461599
    [No Abstract]   [Full Text] [Related]  

  • 13. Fenoterol: enough is enough.
    Garrett JE; Lanes S; Kolbe J; Rea HH
    N Z Med J; 1992 Oct; 105(943):414. PubMed ID: 1461600
    [No Abstract]   [Full Text] [Related]  

  • 14. Beta-agonists and death from asthma.
    Pearce N; Crane J; Burgess C; Beasley R; Jackson R
    N Engl J Med; 1992 Jul; 327(5):355-7. PubMed ID: 1352379
    [No Abstract]   [Full Text] [Related]  

  • 15. The use of beta-agonists and the risk of death and near death from asthma.
    Spitzer WO; Suissa S; Ernst P; Horwitz RI; Habbick B; Cockcroft D; Boivin JF; McNutt M; Buist AS; Rebuck AS
    N Engl J Med; 1992 Feb; 326(8):501-6. PubMed ID: 1346340
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Asthma deaths in New Zealand: whodunnit?
    Blauw GJ; Westendorp RG
    Lancet; 1995 Jan; 345(8941):2-3. PubMed ID: 7799701
    [No Abstract]   [Full Text] [Related]  

  • 17. Long acting beta 2 agonists and the risk of life threatening asthma.
    Ernst P
    Thorax; 1998 Jan; 53(1):1-2. PubMed ID: 9577513
    [No Abstract]   [Full Text] [Related]  

  • 18. Withdrawal of fenoterol and the end of the New Zealand asthma mortality epidemic.
    Beasley R; Pearce N; Crane J; Burgess C
    Int Arch Allergy Immunol; 1995; 107(1-3):325-7. PubMed ID: 7613161
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The saga of the New Zealand asthma mortality epidemic.
    N Z Med J; 1995 Mar; 108(995):91. PubMed ID: 7661939
    [No Abstract]   [Full Text] [Related]  

  • 20. Optical illusions from visual data analysis: example of the New Zealand asthma mortality epidemic.
    Suissa S; Ernst P
    J Clin Epidemiol; 1997 Oct; 50(10):1079-88. PubMed ID: 9368515
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.